During an annual comprehensive health screening, an asymptomatic -year-old man is found to have elevated serum calcium levels. He has no history of nephrolithiasis, bone pain, abdominal discomfort, or psychiatric symptoms. He takes no medications, including over-the-counter supplements. His family history is notable for a brother who was told he had 'calcium problems' but never required surgical intervention. Vital signs and physical examination are unremarkable.
Subsequent laboratory investigations reveal the following:
| Test | Result | Reference Range |
|---|---|---|
| Calcium, total | ||
| Phosphorus | ||
| Albumin | ||
| Creatinine | ||
| Intact parathyroid hormone (PTH) | ||
| 25-hydroxyvitamin D | ||
| 24-hour urine calcium |
Which of the following is the most likely diagnosis?
- AHumoral hypercalcemia of malignancy
- BVitamin D toxicity
- CPrimary hyperparathyroidism
- Familial hypocalciuric hypercalcemiaAnswer
- ESecondary hyperparathyroidism
Answer
Familial hypocalciuric hypercalcemia
The patient has hypercalcemia, hypophosphatemia, and an inappropriately elevated parathyroid hormone (PTH) level, suggesting a PTH-dependent hypercalcemia. However, his 24-hour urine calcium excretion is markedly reduced. This combination of mild, asymptomatic hypercalcemia, normal or slightly elevated PTH, and prominent hypocalciuria is the hallmark of familial hypocalciuric hypercalcemia (FHH). FHH is an autosomal dominant disorder caused by an inactivating mutation in the calcium-sensing receptor (CaSR) in the parathyroid glands and kidneys. The defective receptors require higher serum calcium concentrations to suppress PTH release, and they simultaneously promote excessive renal tubular reabsorption of calcium. This leads to the characteristic hypocalciuria, which is the primary feature distinguishing FHH from primary hyperparathyroidism.
Step-by-Step Solution
Key Concept
Differentiating Familial Hypocalciuric Hypercalcemia (FHH) from Primary Hyperparathyroidism using 24-hour urine calcium levels.